Fermenta Biotech Limited (BOM:506414)

India flag India · Delayed Price · Currency is INR
312.80
+1.45 (0.47%)
At close: Feb 12, 2026
Market Cap9.15B -16.7%
Revenue (ttm)5.44B +27.3%
Net Income869.65M +144.8%
EPS29.54 +140.9%
Shares Out29.43M
PE Ratio10.52
Forward PEn/a
Dividend2.50 (0.80%)
Ex-Dividend DateAug 6, 2025
Volume22,086
Average Volume19,516
Open311.50
Previous Close311.35
Day's Range306.40 - 320.00
52-Week Range219.00 - 399.00
Beta-0.17
RSI42.53
Earnings DateFeb 9, 2026

About Fermenta Biotech

Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally. It provides pharmaceutical formulations and environmental solutions; rents and sells properties; and sports and health awareness/education services. The company also offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for use in various applications, such as pharmaceuticals, dietary and nutritional sup... [Read more]

Industry Pharmaceutical Preparations
Founded 1951
Employees 606
Stock Exchange Bombay Stock Exchange
Ticker Symbol 506414
Full Company Profile

Financial Performance

Financial Statements